Daniel Kraft, MD, is a Stanford- and Harvard-trained physician-scientist, inventor, and investor who has spent more than 25 years at the intersection of clinical medicine, biomedical research, and emerging technology. His work explores how artificial intelligence, continuous data, and converging technologies are reshaping prevention, diagnosis, therapy, and the delivery of care, and, through his Now, Near and Next framework, what leaders, clinicians, and patients can do about it now rather than someday.
He is Founder and Chair of NextMed.Health (which began as Exponential Medicine at Singularity University), a program and community convening clinicians, technologists, investors, and regulators around the future of medicine, and Founder of Digital.Health, a curated platform for discovering and evaluating digital health and AI solutions. He is Co-Founder and General Partner at Continuum Health Ventures, backing early-stage companies working to democratize health and extend healthspan, and serves as an Adjunct Professor of Medicine at Stanford University School of Medicine. He serves on the boards of Healthy.io and Immunis Biomedical, and was founding faculty at Singularity University, where he chaired its medicine program. He served as chair of the XPRIZE Pandemic & Health Alliance.
Questions? Contact Us Any Time:
805.965.1400
info@bigspeak.com
Following undergraduate studies at Brown University and medical school at Stanford, Daniel was board certified in both internal medicine and pediatrics after a Harvard residency at Massachusetts General Hospital and Boston Children’s Hospital, and completed fellowships in hematology, oncology, and bone marrow transplantation at Stanford. His laboratory research in stem cell biology, cancer immunotherapy, and bioengineered T-cell differentiation was published in Nature and Science. He is the founder of RegenMed Systems and the inventor of its FDA-cleared MarrowMiner, a device for minimally invasive bone marrow harvest, and holds patents spanning medical devices, immunology, and stem cell therapies.
A six-time TED and TEDMED speaker who has keynoted on five continents, Daniel advises biopharma boards and executive teams, health systems, and startups on AI and digital health strategy. He wrote the lead article for National Geographic’s special issue on the future of medicine, and his work has been featured by CNN and WIRED, most recently appearing on NewsNation’s The Future is Now town hall alongside Neil deGrasse Tyson and Scott Galloway. He is a member of the inaugural class of the Aspen Institute Health Innovators Fellowship and of the Kauffman Fellows Society. He is an active pilot, served as an officer and flight surgeon with F-15 and F-16 fighter squadrons